AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2018
Jan 4, 2018
31523_dirs_2018-01-04_c31fc87c-80db-4abf-962f-b354cc21cd10.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2018-01-02
Reporting Person: HAYDEN DONALD J JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-02 | Common Stock | M | 20000 | $15.0001 | Acquired | 25814 | Direct |
| 2018-01-02 | Common Stock | S | 20000 | $15.0001 | Disposed | 5814 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-02 | Stock Options (right to buy) | $7.15 | M | 10000 | Disposed | 2019-06-10 | Common Stock (10000) | Direct |
| 2018-01-02 | Stock Options (right to buy) | $10.53 | M | 10000 | Disposed | 2018-06-10 | Common Stock (10000) | Direct |
Footnotes
F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2017.
F2: This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.00 to $15.01. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.00 to $15.01. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.